{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:21:33Z","timestamp":1792844493111,"version":"4.5.0"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To provide an update summarizing the biologic pathways governing von Hippel\u2013Lindau (VHL) disease pathogenesis and to provide an overview of systemic manifestations as well as screening recommendations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A PubMed search of the English language literature was reviewed using the following search terms: von Hippel\u2013Lindau, von Hippel\u2013Lindau disease, and VHL. Of 6,696 publications, the most current and pertinent information related to the pathogenesis and systemic aspects of VHL disease were included in this review.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>von Hippel\u2013Lindau disease is one of the most frequently occurring multisystem familial cancer syndromes. The disease results from germline mutation in the <jats:italic toggle=\"yes\">VHL<\/jats:italic> tumor suppressor gene on the short arm of chromosome 3. Mutation in the <jats:italic toggle=\"yes\">VHL<\/jats:italic> gene affects multiple cellular processes including transcriptional regulation, extracellular matrix formation, apoptosis, and, in particular, the cellular adaptive response to hypoxia. As a result, there is widespread development of vascular tumors affecting the retina, brain, and spine, as well as a spectrum of benign and malignant tumors and\/or cysts in visceral organs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The ophthalmologist plays a key role in VHL disease diagnosis, as retinal hemangioblastoma is frequently the first disease manifestation. Screening guidelines for individuals with known VHL disease, and those at risk of VHL disease, help to ensure early detection of potentially vision-threatening and life-threatening disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000002555","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T21:42:08Z","timestamp":1557870128000},"page":"2243-2253","source":"Crossref","is-referenced-by-count":66,"title":["VON HIPPEL\u2013LINDAU DISEASE"],"prefix":"10.1097","volume":"39","author":[{"given":"Mary E.","family":"Aronow","sequence":"first","affiliation":[{"name":"Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry E.","family":"Wiley","sequence":"additional","affiliation":[{"name":"National Eye Institute, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gaudric","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, H\u00f4pital Lariboisi\u00e8re, AP-HP, Universit\u00e9 Paris 7, Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Krivosic","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, H\u00f4pital Lariboisi\u00e8re, AP-HP, Universit\u00e9 Paris 7, Sorbonne Paris Cit\u00e9, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Gorin","sequence":"additional","affiliation":[{"name":"Jules Stein Eye Institute, David Geffen School of Medicine, University of California, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W.","family":"Jonasch","sequence":"additional","affiliation":[{"name":"Department of Genitourinary Medical Oncology, University of Texas Maryland Anderson Cancer Center, Houston, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun D.","family":"Singh","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[{"name":"National Eye Institute, National Institutes of Health, Bethesda, Maryland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jmg.28.7.443","article-title":"Von Hippel-Lindau disease: a genetic study","volume":"28","author":"Maher","year":"1991","journal-title":"J Med Genet"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0140-6736(91)90401-A","article-title":"Clustering of features and genetics of von Hippel-Lindau syndrome","volume":"338","author":"Neumann","year":"1991","journal-title":"Lancet"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"key":"R5-20230816","first-page":"1","article-title":"Studies on cerebellic cysts: construction, pathogenesis and relationships to retinal angiomatosis [in German]","volume":"1","author":"Lindau","year":"1926","journal-title":"Acta Pathol Microbiol Scand"},{"key":"R6-20230816","first-page":"521","article-title":"Genetic analysis of von Hippel-Lindau disease","volume":"31","author":"Nordstrom-O'Brien","year":"2010","journal-title":"Hum Mutat"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/nar\/26.1.256","article-title":"Software and database for the analysis of mutations in the VHL gene","volume":"26","author":"B\u00e9roud","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"R8-20230816","first-page":"514","article-title":"Mutation and cancer: neuroblastoma and pheochromocytoma","volume":"24","author":"Knudson","year":"1972","journal-title":"Am J Hum Genet"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.ge.20.120186.001311","article-title":"Genetics of human cancer","volume":"20","author":"Knudson","year":"1986","journal-title":"Annu Rev Genet"},{"key":"R10-20230816","first-page":"765","article-title":"Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors","volume":"60","author":"Prowse","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.rcl.2015.12.004","article-title":"von Hippel-Lindau disease: review of genetics and imaging","volume":"54","author":"Shanbhogue","year":"2016","journal-title":"Radiol Clin North Am"},{"key":"R12-20230816","first-page":"55","article-title":"Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease","volume":"48","author":"Conway","year":"2001","journal-title":"Neurosurgery"},{"key":"R13-20230816","first-page":"4845","article-title":"Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas","volume":"54","author":"Kanno","year":"1994","journal-title":"Cancer Res"},{"key":"R14-20230816","first-page":"504","article-title":"Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas","volume":"58","author":"Lee","year":"1998","journal-title":"Cancer Res"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1096-9896(199606)179:2<151::AID-PATH556>3.0.CO;2-0","article-title":"Mutation of the Von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system","volume":"179","author":"Oberstrass","year":"1996","journal-title":"J Pathol"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/107.4.459","article-title":"Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar hemangioblastomas","volume":"107","author":"Tse","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s001099900022","article-title":"Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: an in vivo study on 29 tumors","volume":"77","author":"Brieger","year":"1999","journal-title":"J Mol Med (Berl)"},{"key":"R19-20230816","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A","article-title":"Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC","volume":"13","author":"Gallou","year":"1999","journal-title":"Hum Mutat"},{"key":"R20-20230816","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R21-20230816","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","article-title":"Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome","volume":"34","author":"Nielsen","year":"2016","journal-title":"J Clin Oncol"},{"key":"R22-20230816","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"R23-20230816","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"R24-20230816","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-20230816","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.urolonc.2008.11.001","article-title":"The clinical implications of the genetics of renal cell carcinoma","volume":"27","author":"Rosner","year":"2009","journal-title":"Urol Oncol"},{"key":"R26-20230816","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11934-010-0156-y","article-title":"Impact of genetics on the diagnosis and treatment of renal cancer","volume":"12","author":"Singer","year":"2011","journal-title":"Curr Urol Rep"},{"key":"R27-20230816","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1128\/MCB.00232-06","article-title":"Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3","volume":"26","author":"Hergovich","year":"2006","journal-title":"Mol Cel Biol"},{"key":"R28-20230816","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yexcr.2004.07.016","article-title":"The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery","volume":"301","author":"Lolkema","year":"2004","journal-title":"Exp Cel Res"},{"key":"R29-20230816","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200605092","article-title":"The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth","volume":"175","author":"Schermer","year":"2006","journal-title":"J Cel Biol"},{"key":"R30-20230816","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-05-2560","article-title":"Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis","volume":"66","author":"Kurban","year":"2006","journal-title":"Cancer Res"},{"key":"R31-20230816","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/MCB.26.7.2519-2530.2006","article-title":"pVHL function is essential for endothelial extracellular matrix deposition","volume":"26","author":"Tang","year":"2006","journal-title":"Mol Cel Biol"},{"key":"R32-20230816","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ophtha.2014.06.019","article-title":"Ocular manifestations of hypoxia-inducible factor-2alpha paraganglioma-somatostatinoma-polycythemia syndrome","volume":"121","author":"Pacak","year":"2014","journal-title":"Ophthalmology"},{"key":"R33-20230816","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-0004.2007.00827.x","article-title":"Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification","volume":"72","author":"Hes","year":"2007","journal-title":"Clin Genet"},{"key":"R34-20230816","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/cge.12092","article-title":"Mosaicism in von Hippel-Lindau disease with severe renal manifestations","volume":"84","author":"Wu","year":"2013","journal-title":"Clin Genet"},{"key":"R35-20230816","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1086\/302726","article-title":"Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents","volume":"66","author":"Sgambati","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R36-20230816","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"R37-20230816","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel-Lindau: how a rare disease illuminates cancer biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"R38-20230816","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","article-title":"Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype","volume":"5","author":"Chen","year":"1995","journal-title":"Hum Mutat"},{"key":"R39-20230816","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","article-title":"Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype","volume":"3","author":"Crossey","year":"1994","journal-title":"Hum Mol Genet"},{"key":"R40-20230816","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/jmg.33.8.716","article-title":"Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A","volume":"33","author":"Chen","year":"1996","journal-title":"J Med Genet"},{"key":"R41-20230816","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/jmg.33.4.328","article-title":"Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations","volume":"33","author":"Maher","year":"1996","journal-title":"J Med Genet"},{"key":"R42-20230816","first-page":"495","article-title":"Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations","volume":"103","author":"Chew","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R43-20230816","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1076\/opge.19.3.123.2185","article-title":"The two-stage mutation model in retinal hemangioblastoma","volume":"19","author":"Chang","year":"1998","journal-title":"Ophthalmic Genet"},{"key":"R44-20230816","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ophtha.2007.03.009","article-title":"Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"key":"R45-20230816","first-page":"3067","article-title":"Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study","volume":"43","author":"Dollfus","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R46-20230816","first-page":"232","article-title":"Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary?","volume":"119","author":"Singh","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R47-20230816","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0161-6420(01)00758-8","article-title":"Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease","volume":"108","author":"Singh","year":"2001","journal-title":"Ophthalmology"},{"key":"R48-20230816","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.ophtha.2012.06.026","article-title":"Longitudinal analysis of retinal hemangioblastomatosis and visual function in ocular von Hippel-Lindau disease","volume":"119","author":"Toy","year":"2012","journal-title":"Ophthalmology"},{"key":"R49-20230816","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0301-4738.154384","article-title":"Review of spectral domain-enhanced depth imaging optical coherence tomography of tumors of the retina and retinal pigment epithelium in children and adults","volume":"63","author":"Shields","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"R50-20230816","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/ICB.0000000000000382","article-title":"Clinically invisible retinal hemangioblastomas detected by spectral domain optical coherence tomography and fluorescein angiography in twins","volume":"12","author":"Schoen","year":"2018","journal-title":"Retin Cases Brief Rep"},{"key":"R51-20230816","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/0974-9233.65486","article-title":"Vascular tumors of the retina and choroid: diagnosis and treatment","volume":"17","author":"Turell","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R52-20230816","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ophtha.2008.04.033","article-title":"Intravitreal ranibizumab therapy for retinal capillary hemangioblastoma related to von Hippel-Lindau disease","volume":"115","author":"Wong","year":"2008","journal-title":"Ophthalmology"},{"key":"R53-20230816","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/IAE.0b013e318030a290","article-title":"Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina","volume":"27","author":"Dahr","year":"2007","journal-title":"Retina"},{"key":"R54-20230816","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1755-3768.2010.02008.x","article-title":"Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma","volume":"88","author":"Sachdeva","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R55-20230816","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0039-6257(01)00245-4","article-title":"Von Hippel-Lindau disease","volume":"46","author":"Singh","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R56-20230816","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/S0161-6420(00)00422-X","article-title":"Juxtapapillary capillary hemangiomas. Clinical features and visual acuity outcomes","volume":"107","author":"McCabe","year":"2000","journal-title":"Ophthalmology"},{"key":"R57-20230816","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ophtha.2010.04.031","article-title":"Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease","volume":"118","author":"Gaudric","year":"2011","journal-title":"Ophthalmology"},{"key":"R58-20230816","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(03)00101-6","article-title":"Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas","volume":"136","author":"Girmens","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R59-20230816","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004397-199703740-00014","article-title":"Advances in treatment of retinal angiomas","volume":"37","author":"Palmer","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"R60-20230816","first-page":"61","article-title":"Retina hemangiomas: understanding clinical features, imaging, and therapies","volume":"10","author":"Shields","year":"2015","journal-title":"Retina Today"},{"key":"R61-20230816","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/eye.2012.259","article-title":"Photodynamic therapy for retinal capillary hemangioma","volume":"27","author":"Papastefanou","year":"2013","journal-title":"Eye (Lond)"},{"key":"R62-20230816","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0161-6420(02)01059-X","article-title":"Benefits and complications of photodynamic therapy of papillary capillary hemangiomas","volume":"109","author":"Schmidt-Erfurth","year":"2002","journal-title":"Ophthalmology"},{"key":"R63-20230816","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00417-014-2660-0","article-title":"Upregulation of hypoxia-inducible factors and autophagy in von Hippel-Lindau-associated retinal hemangioblastoma","volume":"252","author":"Wang","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R64-20230816","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1167\/iovs.10-5223","article-title":"Genotype-phenotype correlation in ocular von Hippel-Lindau (VHL) disease: the effect of missense mutation position on ocular VHL phenotype","volume":"51","author":"Mettu","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R65-20230816","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","article-title":"The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease","volume":"98","author":"Wanebo","year":"2003","journal-title":"J Neurosurg"},{"key":"R66-20230816","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3171\/jns.2003.98.1.0095","article-title":"Surgical management of brainstem hemangioblastomas in patients with von Hippel-Lindau disease","volume":"98","author":"Weil","year":"2003","journal-title":"J Neurosurg"},{"key":"R67-20230816","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","article-title":"von Hippel-Lindau disease: genetic, clinical, and imaging features","volume":"194","author":"Choyke","year":"1995","journal-title":"Radiology"},{"key":"R68-20230816","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/rg.281075052","article-title":"Imaging features of von Hippel-Lindau disease","volume":"28","author":"Leung","year":"2008","journal-title":"Radiographics"},{"key":"R69-20230816","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3171\/2015.4.JNS1533","article-title":"Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease","volume":"124","author":"Huntoon","year":"2016","journal-title":"J Neurosurg"},{"key":"R70-20230816","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease","volume":"120","author":"Lonser","year":"2014","journal-title":"J Neurosurg"},{"key":"R71-20230816","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/JNS\/2008\/108\/2\/0210","article-title":"Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease","volume":"108","author":"Jagannathan","year":"2008","journal-title":"J Neurosurg"},{"key":"R72-20230816","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3171\/jns.2006.105.2.248","article-title":"Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment","volume":"105","author":"Ammerman","year":"2006","journal-title":"J Neurosurg"},{"key":"R73-20230816","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006123-199807000-00018","article-title":"Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery","volume":"43","author":"Chang","year":"1998","journal-title":"Neurosurgery"},{"key":"R74-20230816","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3171\/sup.2005.102.s_supplement.0220","article-title":"Long-term results of Leksell gamma knife surgery for trigeminal schwannomas","volume":"102","author":"Pan","year":"2005","journal-title":"J Neurosurg"},{"key":"R75-20230816","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.otc.2014.12.006","article-title":"Endolymphatic sac tumors","volume":"48","author":"Wick","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"key":"R76-20230816","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1288\/00005537-199508000-00006","article-title":"Endolymphatic sac tumors: histopathologic confirmation, clinical characterization, and implication in von Hippel-Lindau disease","volume":"105","author":"Megerian","year":"1995","journal-title":"Laryngoscope"},{"key":"R77-20230816","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/ICB.0b013e318124a4c8","article-title":"Endolymphatic sac tumor as initial manifestation of von Hippel-Lindau syndrome","volume":"2","author":"Salazar","year":"2008","journal-title":"Retin Cases Brief Rep"},{"key":"R78-20230816","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2214\/ajr.175.3.1750925","article-title":"Endolymphatic sac tumor and von Hippel-Lindau disease: imaging features","volume":"175","author":"Ayadi","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"R79-20230816","first-page":"12","article-title":"Surgical management of endolymphatic sac tumors","volume":"74","author":"Friedman","year":"2013","journal-title":"J Neurol Surg B Skull Base"},{"key":"R80-20230816","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"R81-20230816","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-5347(17)55236-2","article-title":"Polycystic kidneys as the renal lesion in Lindau's disease","volume":"125","author":"Frimodt-Moller","year":"1981","journal-title":"J Urol"},{"key":"R82-20230816","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.20385","article-title":"Genotype-phenotype correlations in von Hippel-Lindau disease","volume":"28","author":"Ong","year":"2007","journal-title":"Hum Mutat"},{"key":"R83-20230816","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00005392-199501000-00009","article-title":"Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications","volume":"153","author":"Poston","year":"1995","journal-title":"J Urol"},{"key":"R84-20230816","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ncpuro0179","article-title":"Management of von Hippel-Lindau-associated kidney cancer","volume":"2","author":"Grubb","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"R85-20230816","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","article-title":"Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery","volume":"161","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"R86-20230816","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/archsurg.137.6.682","article-title":"Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery","volume":"137","author":"Baghai","year":"2002","journal-title":"Arch Surg"},{"key":"R87-20230816","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","article-title":"von Hippel-Lindau disease","volume":"76","author":"Maher","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"R88-20230816","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0016-5085(91)90026-H","article-title":"Pancreatic lesions in the von Hippel-Lindau syndrome","volume":"101","author":"Neumann","year":"1991","journal-title":"Gastroenterology"},{"key":"R89-20230816","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPA.0b013e31815f394a","article-title":"Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features","volume":"37","author":"Corcos","year":"2008","journal-title":"Pancreas"},{"key":"R90-20230816","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1067\/msy.2000.110239","article-title":"Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease","volume":"128","author":"Libutti","year":"2000","journal-title":"Surgery"},{"key":"R91-20230816","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0022-5347(17)49380-3","article-title":"Bilateral clear cell papillary cystadenoma of the epididymides presenting as infertility: an early manifestation of von Hippel-Lindau's syndrome","volume":"133","author":"Witten","year":"1985","journal-title":"J Urol"},{"key":"R92-20230816","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2214\/ajr.153.3.527","article-title":"Papillary cystadenoma of the broad ligament in a patient with von Hippel-Lindau disease","volume":"153","author":"Funk","year":"1989","journal-title":"AJR Am J Roentgenol"},{"key":"R93-20230816","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"R94-20230816","first-page":"1","article-title":"Benefits of screening in von Hippel-Lindau disease\u2014comparison of morbidity associated with initial tumours in affected parents and children","volume":"66","author":"Priesemann","year":"2006","journal-title":"Horm Res"},{"key":"R95-20230816","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00268-001-0221-2","article-title":"Influence of exogenous fat emulsion on pulmonary gas exchange after major surgery","volume":"26","author":"Sane","year":"2002","journal-title":"World J Surg"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:28:58Z","timestamp":1692232138000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000002555"}},"subtitle":["Update on Pathogenesis and Systemic Aspects"],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":95,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000002555","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}